Global Cannabis and CBD News Roundup YouTube
Hi,

The DEA's commitment to a timeline for the federal cannabis scheduling review is a step in the right direction. Everyone wonders if cannabis will be de-scheduled, re-scheduled or kept as is. There is a theory that tobacco giant Philip Morris's $650M purchase of an Israeli inhalable cannabis delivery company might indicate that they have advanced word that the Biden administration is going to push to re-schedule cannabis. The pursuit of legalizing cannabis in Germany faces potential clashes with EU law, particularly with the concept of 'cannabis clubs.' Come on Germany, you tried to take over the world twice. I think you can stand up to the EU to tell them to get away from your joints. ;)

Feel free to subscribe to our Cannabis or CBD News Roundups.

Thanks and have a sunny week,
Jessica

Weekly News
pic10
Big Tobacco Bets Big On Cannabis More at jdsupra.com...
pic10
German Cannabis Legalisation Could Infringe EU Law despite Tweaks More at euractiv.com...
pic10
DEA Head Commits To Request Cannabis Review Timeline From Health Agency More at marijuanamoment.net...
pic10
Analysis: One in Seven Canadians Use Cannabis to Recover from Work-Related Injuries More at norml.org...
pic10
Michigan Cannabis Companies Wanted a Crackdown on Unlicensed Cannabis More at greenmarketreport.com...
pic10
Flax and Hemp Are Sustainable Building Materials: Research More at dutchnews.nl...
pic10
Mastercard Moves to Ban Cannabis Purchases on Its Debit Cards More at reuters.com...
pic10
Legendary Tech Billionaire Accused of Fraud in Pot Startup Lawsuit More at sfgate.com...
pic10
Nevada Cannabis Companies Cite Big Wins from Legislative Session More at mjbizdaily.com...
pic10
Cannabeginners: How To Legally Use Cannabis In South Africa More at hightimes.com...
pic10
Jammu to Pioneer India’s First Cannabis Medicine Project More at iiim.res.in...
pic10
B.C. Judge Allows Cannabis ’Fire Sale’ to Stave off CRA Destruction Threat More at vancouversun.com...
Cool Finds
pic13
Fantastic Funghi Documentary More at fantasticfungi.com...
pic14
Magic Mushrooms In Oaxaca More at hightimes.com...
Stocks and Startups Briefs

07/24/23
Massachusetts Social Equity Fund fails to distribute aid to social equity cannabis companies despite lawmakers' efforts in 2022.
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) to sell Ohio dispensary for over $8M, focusing on other statewide stakes.

07/25/23
Aleafia Health Inc. (TSX: AH) (OTCQB: ALEAF) files for creditor protection due to financial struggles following a canceled acquisition deal.
Parallel's subsidiary seeks to avoid a $6M payment by declaring insolvency after a failed grow facility.
Detroit opens applications for limited marijuana business licenses, including dispensaries, microbusinesses, and consumption lounges.
Flora Growth Corp. (Nasdaq: FLGC) sells Colombian assets for C$800K, maintaining Latin American presence through Just Brands.
MIRA Pharmaceuticals plans to go public on Nasdaq under "MIRA" to fund clinical studies for FDA approval of its synthetic cannabis drug.
Missouri begins accepting cannabis microbusiness applications, with a lottery to select winners by September 1.

07/26/23
Tilray Brands Inc. (Nasdaq: TLRY) (TSX: TLRY) stock jumps over 20% after posting strong revenue and adjusted EBIDTA in Q4.
SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) reports diversification, with cannabis holdings now at 20% of its business.
Chris Webber scales back $175M Detroit cannabis plan due to falling marijuana prices, but still has future plans.
Craft 1861 Global Inc. plans to divest its New Mexico plant-touching operations to RKA LLC.
Oklahoma authorities arrest a licensed grow facility owner after finding thousands of untagged cannabis plants and over 600 pounds of untagged cannabis.

07/27/23
Tilray's Q4 results impress with better-than-expected top-line performance, despite challenges in the cannabis market.
Auxly Cannabis Group Inc. (TSX: XLY) (OTCQX: CBWTF) extends debenture maturity with partner Imperial Brands PLC until September 2026.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) delivers strong Q3 results, reporting increased revenue and net income.
Missouri regulators gain power to fine, suspend, or revoke licenses of medical-marijuana businesses for violating rules.

Inspiration